27839

    544306

    SAILIFE

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SAI LIFE SCIENCES LIMITED Share Price Today

    SAI LIFE SCIENCES LIMITED is currently trading at ₹1247.9, up by ₹26.59 from the previous close. The stock touched an intraday high of ₹1260.00 and a low of ₹1211.00 during the latest trading session. Over the past one year, SAI LIFE SCIENCES LIMITED has delivered a return of 60.87%, while the stock has gained 3.86% in the last one month.

    SAI LIFE SCIENCES LIMITED performance

    Today’s low Today’s high
    ₹ 1211.00 ₹ 1260.00
    ₹ 1247.90
    52 week low 52 week high
    ₹ 744.10 ₹ 1260.00
    ₹ 1247.90
    Open Price ₹ 1223.00
    Prev. Close ₹ 1221.30
    Volume (Shares) 1162241.00
    Total traded value ₹ 14503.60
    Upper Circuit ₹ 1465.50
    Lower Circuit ₹ 977.10
    info

    Investment Returns

    Over 1 Month 3.86% Over 3 Months 20.64% Over 6 Months 36.22% Over 1 Year 60.87%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SAI LIFE SCIENCES LIMITED fundamentals


    • Market cap (Cr) 26,491.20
    • P/E Ratio (TTM) 75.93
    • Beta 0.91
    • Book Value / share 118.14
    • Return on equity 10.92%
    • EPS (TTM) 16.37
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 102.53
    info icon alternate text
    • Market cap (Cr) 26,492.20
    • P/E Ratio (TTM) 75.93
    • Beta 0.80
    • Book Value / share 118.14
    • Return on equity 10.92%
    • EPS (TTM) 16.37
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 102.53
    info icon alternate text

    SAI LIFE SCIENCES LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 594.34
    Operating Expense 473.52
    Net Profit 102.53
    Net Profit Margin (%) 17.25
    Earnings Per Share (EPS) 4.85
    EBITDA 184.17
    Effective Tax Rate (%) 25.07
    Particulars DEC 2025 (Values in Cr)
    Revenue 549.18
    Operating Expense 418.86
    Net Profit 97.63
    Net Profit Margin (%) 17.77
    Earnings Per Share (EPS) 4.64
    EBITDA 179.13
    Effective Tax Rate (%) 25.17
    Particulars SEP 2025 (Values in Cr)
    Revenue 526.67
    Operating Expense 430.72
    Net Profit 82.95
    Net Profit Margin (%) 15.74
    Earnings Per Share (EPS) 3.97
    EBITDA 154.78
    Effective Tax Rate (%) 25.18
    Particulars JUN 2025 (Values in Cr)
    Revenue 483.04
    Operating Expense 415.07
    Net Profit 58.37
    Net Profit Margin (%) 12.08
    Earnings Per Share (EPS) 2.80
    EBITDA 123.01
    Effective Tax Rate (%) 25.14
    Particulars MAR 2025 (Values in Cr)
    Revenue 567.01
    Operating Expense 456.36
    Net Profit 89.94
    Net Profit Margin (%) 15.86
    Earnings Per Share (EPS) 4.32
    EBITDA 163.73
    Effective Tax Rate (%) 25.34
    Particulars MAR 2026 (Values in Cr)
    Revenue 2153.23
    Operating Expense 1738.18
    Net Profit 341.48
    Net Profit Margin (%) 15.85
    Earnings Per Share (EPS) 16.27
    EBITDA 641.09
    Effective Tax Rate (%) 25.14
    Particulars MAR 2025 (Values in Cr)
    Revenue 1642.05
    Operating Expense 1447.67
    Net Profit 173.46
    Net Profit Margin (%) 10.56
    Earnings Per Share (EPS) 9.00
    EBITDA 427.79
    Effective Tax Rate (%) 25.13
    Particulars MAR 2024 (Values in Cr)
    Revenue 1418.68
    Operating Expense 1319.01
    Net Profit 95.23
    Net Profit Margin (%) 6.71
    Earnings Per Share (EPS) 52.57
    EBITDA 315.94
    Effective Tax Rate (%) 26.17
    Particulars MAR 2023 (Values in Cr)
    Revenue 1157.40
    Operating Expense 1152.68
    Net Profit 24.24
    Net Profit Margin (%) 2.09
    Earnings Per Share (EPS) 14.26
    EBITDA 191.10
    Effective Tax Rate (%) 25.84
    Particulars MAR 2022 (Values in Cr)
    Revenue 841.02
    Operating Expense 846.82
    Net Profit 15.68
    Net Profit Margin (%) 1.86
    Earnings Per Share (EPS) 10.12
    EBITDA 149.54
    Effective Tax Rate (%) 29.84
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 102.12
    ROE % 10.97
    ROCE % 13.82
    Total Debt to Total Equity 0.42
    EBITDA Margin 26.24
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 551.96
    ROE % 8.89
    ROCE % 10.56
    Total Debt to Total Equity 0.87
    EBITDA Margin 21.58
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 503.80
    ROE % 1.13
    ROCE % 5.42
    Total Debt to Total Equity 0.82
    EBITDA Margin 16.28
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 500.21
    ROE % -0.58
    ROCE % 3.12
    Total Debt to Total Equity 0.80
    EBITDA Margin 16.45
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 494.88
    ROE % 7.37
    ROCE % 8.55
    Total Debt to Total Equity 0.57
    EBITDA Margin 25.61
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 104.00
    ROE % 10.92
    ROCE % 13.87
    Total Debt to Total Equity 0.36
    EBITDA Margin 26.17
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 572.28
    ROE % 9.90
    ROCE % 11.36
    Total Debt to Total Equity 0.90
    EBITDA Margin 22.37
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 517.79
    ROE % 2.69
    ROCE % 5.96
    Total Debt to Total Equity 0.90
    EBITDA Margin 16.83
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 507.50
    ROE % 0.50
    ROCE % 3.72
    Total Debt to Total Equity 0.79
    EBITDA Margin 16.85
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 486.92
    ROE % 7.86
    ROCE % 8.93
    Total Debt to Total Equity 0.57
    EBITDA Margin 25.48
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 463.88
    Total Assets 3159.97
    Total Liabilities 3159.97
    Total Equity 2128.35
    Share Outstanding 20
    Price to Book Ratio 7.33
    Return on Assets (%) 5.38
    Return on Capital (%) 7.54
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 158.80
    Total Assets 2275.13
    Total Liabilities 2275.13
    Total Equity 975.14
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 3.63
    Return on Capital (%) 4.91
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 86.33
    Total Assets 2186.64
    Total Liabilities 2186.64
    Total Equity 888.09
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 0.45
    Return on Capital (%) 0.63
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 130.29
    Total Assets 2157.34
    Total Liabilities 2157.34
    Total Equity 878.56
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 0.28
    Return on Capital (%) 0.38
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 76.41
    Total Assets 1817.41
    Total Liabilities 1817.41
    Total Equity 862.95
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 3.36
    Return on Capital (%) 4.07
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 457.95
    Total Assets 3136.66
    Total Liabilities 3136.66
    Total Equity 2167.46
    Share Outstanding 20
    Price to Book Ratio 7.33
    Return on Assets (%) 5.53
    Return on Capital (%) 7.55
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 152.00
    Total Assets 2239.92
    Total Liabilities 2239.92
    Total Equity 1011.19
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 4.25
    Return on Capital (%) 5.53
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 80.01
    Total Assets 2130.62
    Total Liabilities 2130.62
    Total Equity 912.73
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 1.13
    Return on Capital (%) 1.5
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 123.52
    Total Assets 2105.89
    Total Liabilities 2105.89
    Total Equity 891.03
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 0.74
    Return on Capital (%) 0.95
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 70.09
    Total Assets 1816.48
    Total Liabilities 1816.48
    Total Equity 867.51
    Share Outstanding 1
    Price to Book Ratio 0.00
    Return on Assets (%) 3.59
    Return on Capital (%) 4.34
    Particulars MAR 2025 (Values in Cr)
    Net Income 227.70
    Cash from Operations 335.67
    Cash from Investing -536.66
    Cash from Financing 301.42
    Net change in Cash 78.80
    Free Cash Flow 704.95
    Particulars MAR 2024 (Values in Cr)
    Net Income 109.23
    Cash from Operations 276.96
    Cash from Investing -192.38
    Cash from Financing -95.29
    Net change in Cash -24.59
    Free Cash Flow 458.65
    Particulars MAR 2023 (Values in Cr)
    Net Income 16.40
    Cash from Operations 223.48
    Cash from Investing -101.78
    Cash from Financing -200.64
    Net change in Cash -83.02
    Free Cash Flow 336.55
    Particulars MAR 2022 (Values in Cr)
    Net Income 9.69
    Cash from Operations 112.98
    Cash from Investing -103.71
    Cash from Financing 71.92
    Net change in Cash 75.15
    Free Cash Flow 319.90
    Particulars MAR 2021 (Values in Cr)
    Net Income 81.91
    Cash from Operations -20.93
    Cash from Investing -259.89
    Cash from Financing 295.49
    Net change in Cash -0.77
    Free Cash Flow 241.13
    Particulars MAR 2025 (Values in Cr)
    Net Income 231.71
    Cash from Operations 351.82
    Cash from Investing -564.71
    Cash from Financing 314.31
    Net change in Cash 79.95
    Free Cash Flow 715.31
    Particulars MAR 2024 (Values in Cr)
    Net Income 129.00
    Cash from Operations 264.13
    Cash from Investing -190.05
    Cash from Financing -84.63
    Net change in Cash -24.03
    Free Cash Flow 443.49
    Particulars MAR 2023 (Values in Cr)
    Net Income 32.68
    Cash from Operations 225.55
    Cash from Investing -111.22
    Cash from Financing -190.04
    Net change in Cash -79.79
    Free Cash Flow 339.53
    Particulars MAR 2022 (Values in Cr)
    Net Income 22.35
    Cash from Operations 96.48
    Cash from Investing -94.63
    Cash from Financing 80.95
    Net change in Cash 74.69
    Free Cash Flow 294.31
    Particulars MAR 2021 (Values in Cr)
    Net Income 87.58
    Cash from Operations -9.23
    Cash from Investing -279.45
    Cash from Financing 303.57
    Net change in Cash -1.81
    Free Cash Flow 231.82
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.51 13.02 1.52 241.47 23.12 38.85
    BLISS GVS PHARMA LTD 492.50 39.98 4.37 5223.27 118.35 495.00
    CIPLA LTD 1440.30 30.57 3.37 116353.96 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 365.50 16.12 2.64 1075.70 256.40 399.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.51 22.03 4.05 241.47 23.12 38.85
    AMRUTAJAN HEALTH LTD 538.05 24.12 4.20 1555.54 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8382.65 109.48 24.01 20956.63 7630.00 9850.00
    BLISS GVS PHARMA LTD 492.50 53.13 4.52 5223.27 118.35 495.00

    SAI LIFE SCIENCES LIMITED shareholding pattern

    Holding
    12.68%
    34.6%
    21.16%
    31.54%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SAI LIFE SCIENCES LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1247.90 2.17 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 1212.90
    • 26 Days 1176.80
    • 10 Days 1207.20
    • 50 Days 1131.00
    • 12 Days 1204.10
    • 100 Days 1062.50
    • 20 Days 1189.00
    • 200 Days 978.20
    1211.50 PIVOT
    First Support 1195.00 First Resistance 1237.80 Second Support 1168.70 Second Resistance 1254.30 Third Support 1152.20 Third Resistance 1280.60
    RSI 60.70 ADX 53.09 MACD 27.22 Williams % R -31.88 Commodity Channel Index (CCI) 56.14
    Date 2026-06-25 Week 258646.00 Same Day 311948.00 Month 254049.00
    1 Year 0.91 3 Year 1.04
    Over 1 Month
    3.86% down
    Over 1 Year
    60.87% down
    Over 3 Months
    20.64% down
    Over 3 Years
    0.00% down
    Over 6 Months
    36.22% down
    Over 5 Years
    0.00% down

    SAI LIFE SCIENCES LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Sai Life Sciences Ltd?

    Answer Field

    Sai Life Sciences Ltd share price is for NSE ₹ 1,247.90 & for BSE ₹ 1,247.95 as on Jun 29 2026 03:30 PM.

    What is the Market Cap of Sai Life Sciences Ltd Share?

    Answer Field

    The market cap of Sai Life Sciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jun 29 2026 03:30 PM.

    What is the 52 Week High and Low of Sai Life Sciences Ltd?

    Answer Field

    The 52 Week High and Low of Sai Life Sciences Ltd for NSE is ₹ 1,260.00 and ₹ 744.10 and for BSE is ₹ 1,260.00 and ₹ 745.00.

    What is 1 year return for Sai Life Sciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 60.87%.

    What is the P/E Ratio of Sai Life Sciences Ltd Share?

    Answer Field

    As on Jun 29 2026 03:30 PM the price-to-earnings (PE) ratio for Sai Life Sciences Ltd share is 75.93.

    What is the PB ratio of Sai Life Sciences Ltd Share?

    Answer Field

    As on Jun 29 2026 03:30 PM, the price-to-book (PB) ratio for Sai Life Sciences Ltd share is 118.14.

    How to Buy Sai Life Sciences Ltd Share?

    Answer Field

    You can trade in Sai Life Sciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Sai Life Sciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Sai Life Sciences Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Sai Life Sciences Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |